{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:14:17Z","timestamp":1790709257223,"version":"4.1.0"},"reference-count":48,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background\/Objectives: This retrospective study investigates the prevalence and distribution of HCV genotypes among 233 genotyped patients from the Epirus region of Northwestern Greece from 2014 to 2024. Methods: Genotypes were detected by molecular diagnostic assays, and their association with demographic parameters and viral load was analyzed. Results: The most prevalent subtype was 3a (50.2%), especially among younger and male patients, followed by subtypes 1b and 1a. A statistically significant association was found between genotype and both age and sex, while genotype distribution did not significantly differ by national origin. Furthermore, subtype 6c-I was found only in a non-native case, suggesting a possible introduction of this rare strain. Viral load showed no significant difference by sex, genotype, or age group. A notable decline in HCV cases was documented during the COVID-19 pandemic, underscoring the impact of the public health crisis on HCV diagnosis. Despite the decreasing need for genotyping in the direct-acting antiviral (DAA) era, our findings support the continued molecular surveillance of circulating HCV strains. Conclusions: This is the first study to longitudinally assess HCV genotype dynamics over a full decade (2014\u20132024) in the Epirus region of Northwestern Greece, capturing trends during the COVID-19 era and documenting the emergence of rare genotypes. It contributes to the evolving knowledge of HCV epidemiology in Southeastern Europe.<\/jats:p>","DOI":"10.3390\/diseases14040126","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:09:21Z","timestamp":1775038161000},"page":"126","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genotypic Distribution and Epidemiological Analysis of Hepatitis C Virus in the Epirus Region of Northwestern Greece (2014\u20132024)"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4058-1164","authenticated-orcid":false,"given":"Petros","family":"Bozidis","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece"},{"name":"Department of Microbiology, University Hospital of Ioannina, 45500 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-897X","authenticated-orcid":false,"given":"Christos","family":"Kittas","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University Hospital of Ioannina, 45500 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0139-6468","authenticated-orcid":false,"given":"Alexandra","family":"Myari","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3959-8638","authenticated-orcid":false,"given":"Konstantinos","family":"Patras","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University Hospital of Ioannina, 45500 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Gartzonika","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece"},{"name":"Department of Microbiology, University Hospital of Ioannina, 45500 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2025, April 01). Hepatitis C. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_2","unstructured":"World Health Organization (WHO) (2024). Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"key":"ref_3","unstructured":"World Health Organization (WHO) (2021). Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2021: Accountability for the Global Health Sector Strategies 2016\u20132021, WHO. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-hiv-hepatitis-and-stis-library\/who_global_report_2021_webinar-lowbeer.pdf?sfvrsn=c82b4d6e_7."},{"key":"ref_4","unstructured":"Polaris Observatory HCV Collaborators (2022). Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: A modelling study. Lancet Gastroenterol. Hepatol., 7, 396\u2013415."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","article-title":"The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: A modelling study","volume":"4","author":"Trickey","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_7","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2025, April 05). Hepatitis C\u2014Annual Epidemiological Report for 2022, Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hepatitis-c-annual-epidemiological-report-2022."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.3748\/wjg.v22.i36.8094","article-title":"Epidemiology of hepatitis C in Greece","volume":"22","author":"Triantos","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_10","first-page":"26","article-title":"Significant epidemiological changes in chronic hepatitis C infection: Results of the nationwide HEPNET-GREECE cohort study","volume":"15","author":"Raptopoulou","year":"2011","journal-title":"Hippokratia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2893.2005.00649.x","article-title":"Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates","volume":"13","author":"Katsoulidou","year":"2006","journal-title":"J. Viral Hepat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/jvh.13951","article-title":"Incidence of primary hepatitis C infection among people who inject drugs during 2012\u20132020 in Athens, Greece","volume":"31","author":"Roussos","year":"2024","journal-title":"J. Viral Hepat."},{"key":"ref_13","first-page":"35","article-title":"Migration to Greece from the Balkans","volume":"2","author":"Cavounidis","year":"2004","journal-title":"South-East. Eur. J. Econ. Assoc. Econ. Univ. South East. Eur. Black Sea Reg."},{"key":"ref_14","unstructured":"International Organization for Migration (IOM) United Nations (UN) Migration (2025, May 28). EU Migrant, Refugee Arrivals by Land and Sea Approach One Million in 2015. Available online: https:\/\/www.iom.int\/news\/eu-migrant-refugee-arrivals-land-and-sea-approach-one-million-2015?utm_source."},{"key":"ref_15","unstructured":"The American Association for the Study of Liver Diseases (AASLD) (2025, May 29). HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Available online: https:\/\/www.hcvguidelines.org\/sites\/default\/files\/full-guidance-pdf\/AASLD-IDSA_HCVGuidance_December_19_2023.pdf."},{"key":"ref_16","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2025, May 03). Monitoring of Responses to the Hepatitis B and C Epidemics in EU\/EEA Countries\u20142020 Data, Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/monitoring-responses-hepatitis-b-and-c-epidemics-eueea-countries-2020-data."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"106465","DOI":"10.1016\/j.jinf.2025.106465","article-title":"Direct-acting antiviral treatment outcomes in people infected with endemic compared to epidemic hepatitis C virus subtypes in England","volume":"90","author":"Phillips","year":"2025","journal-title":"J. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1136\/gutjnl-2024-332177","article-title":"\u2018Unusual\u2019 HCV genotype subtypes: Origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment","volume":"73","author":"Pawlotsky","year":"2024","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"104873","DOI":"10.1016\/j.jcv.2021.104873","article-title":"Diagnosis and monitoring of hepatitis C virus infection using the cobas\u00ae HCV test for use on the cobas\u00ae 4800 system","volume":"141","author":"Ortonne","year":"2021","journal-title":"J. Clin. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/JCM.02390-07","article-title":"Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0","volume":"46","author":"Verbeeck","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_21","unstructured":"Fujirebio Europe (2025, July 01). Fujirebio Europe Launches the INNO-LiPA\u00ae HCV 2.0 Genotyping Assay, an Efficient Aid to Personalized HCV Therapy. Available online: https:\/\/www.fujirebio.com\/en\/news-events\/fujirebio-europe-launches-the-innolipar-hcv-20-genotyping-assay-an-efficient-aid-to."},{"key":"ref_22","first-page":"434","article-title":"Hepatitis C virus reinfection: A review of the topic and case report","volume":"37","author":"Orrego","year":"2022","journal-title":"Rev. Colomb. De Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An update of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e22876","DOI":"10.1002\/jcla.22876","article-title":"Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review","volume":"33","author":"Petruzziello","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/gheg.2019.4","article-title":"Distribution of Hepatitis C Virus genotypes in northern Greece in the last decade: Descriptive analysis and clinical correlations","volume":"4","author":"Gioula","year":"2019","journal-title":"Glob. Health Epidemiol. Genom."},{"key":"ref_26","first-page":"1048","article-title":"Distribution of Hepatitis C Virus Genotypes Among Chronic HCV Patients in Greece from 2004 to 2019: Association of Genotypes and Viral Load with Gender and Age","volume":"7","author":"Mpekoulis","year":"2022","journal-title":"J. Hepat. Res."},{"key":"ref_27","first-page":"285","article-title":"Genomic and Epidemiological Surveillance of SARS-CoV-2 Epidemic in Northwestern Greece","volume":"69","author":"Sakaloglou","year":"2024","journal-title":"Acta Microbiol. Hell."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Brouard, C., Schwager, M., Expert, A., Drewniak, N., Laporal, S., de Lagasnerie, G., and Lot, F. (2024). Impact of Public Policy and COVID-19 Pandemic on Hepatitis C Testing and Treatment in France, 2014\u20132021. Viruses, 16.","DOI":"10.3390\/v16050792"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S2468-1253(21)00029-7","article-title":"COVID-19 hits viral hepatitis care for vulnerable populations","volume":"6","author":"Samarasekera","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Morrow, R.L., Binka, M., Li, J., Irvine, M., Bartlett, S.R., Wong, S., Jeong, D., Makuza, J.D., Wong, J., and Yu, A. (2024). Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study. Viruses, 16.","DOI":"10.3390\/v16050655"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gastrohep.2017.09.004","article-title":"Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years","volume":"41","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_32","first-page":"7","article-title":"Distribution of Hepatitis C Virus Genotypes in Patients Diagnosed with Hepatitis C in Our Hospital: 2015\u20132018","volume":"10","author":"Hacisyitoglu","year":"2021","journal-title":"Mediterr. J. Infect. Microb. Antimicrob."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2008.02.001","article-title":"Changing HCV genotypes distribution in Poland--relation to source and time of infection","volume":"42","author":"Chlabicz","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sahibzada, K.I., Ganova-Raeva, L., Dimitrova, Z., Ramachandran, S., Lin, Y., Longmire, G., Arthur, L., Xia, G.L., Khudyakov, Y., and Khan, I. (2022). Hepatitis C virus transmission cluster among injection drug users in Pakistan. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0270910"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.meegid.2014.09.009","article-title":"Identification of Indian sub-continent as hotspot for HCV genotype 3a origin by Bayesian evolutionary reconstruction","volume":"28","author":"Choudhary","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e70049","DOI":"10.1002\/jgh3.70049","article-title":"Distribution and inflammatory potential of hepatitis C virus genotypes in the United States, 2011\u20132020","volume":"8","author":"Gnanapandithan","year":"2024","journal-title":"JGH Open"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Abomughaid, M., Tay, E.S.E., Pickford, R., Malladi, C., Read, S.A., Coorssen, J.R., Gloss, B.S., George, J., and Douglas, M.W. (2023). PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108781"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz, M. (2021). Hepatitis C Virus Uses Host Lipids to Its Own Advantage. Metabolites, 11.","DOI":"10.3390\/metabo11050273"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3350\/cmh.2022.0349","article-title":"Acute hepatitis C virus infection: Clinical update and remaining challenges","volume":"29","author":"Liu","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Magri, A., Manfredi, G.F., Smirne, C., Pigni, S., Burlone, M.E., Bellan, M., Vercellino, N., Minisini, R., and Pirisi, M. (2024). Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection. Viruses, 17.","DOI":"10.3390\/v17010021"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1743-422X-7-317","article-title":"Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients","volume":"7","author":"Elasifer","year":"2010","journal-title":"Virol. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1186\/s40064-016-3224-z","article-title":"Age and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central China","volume":"5","author":"Niu","year":"2016","journal-title":"Springerplus"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"102596","DOI":"10.1016\/j.eclinm.2024.102596","article-title":"Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: Systematic review and meta-analysis","volume":"72","author":"Levinsson","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.14309\/ajg.0000000000001095","article-title":"Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis C","volume":"116","author":"Li","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"110430","DOI":"10.4254\/wjh.v17.i10.110430","article-title":"Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals","volume":"17","author":"Feyissa","year":"2025","journal-title":"World J. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Barbaglia, M.N., Harris, J.M., Smirnov, A., Burlone, M.E., Rigamonti, C., Pirisi, M., Minisini, R., and Magri, A. (2022). 17\u03b2-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon. Viruses, 14.","DOI":"10.3390\/v14081806"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Wei, X., Hong, L., Liang, H., Ren, K., Man, W., Zhao, Y., and Guo, P. (2025). Estrogen and viral infection. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1556728"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2020). Clinical Practice Guidelines Panel: Chair; EASL Governing Board representative; Panel members. EASL recommendations on treatment of hepatitis C: Final update of the series. J. Hepatol., 73, 1170\u20131218. Erratum in J. Hepatol.\u00a02023, 78, 452. https:\/\/doi.org\/10.1016\/j.jhep.2022.10.006.","DOI":"10.1016\/j.jhep.2022.10.006"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/4\/126\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:34:40Z","timestamp":1775039680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/4\/126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["diseases14040126"],"URL":"https:\/\/doi.org\/10.3390\/diseases14040126","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}